demonstrated that co‐administration of curcumin with chemotherapeutic agents in gastric cancer significantly elevated apoptotic markers and diminished chemoresistance, primarily via the inhibition of NF‐κB signaling, a key mediator in inflammation and cell survival (Najafi et al. 2020). Here, NFKB1 is linked to gastric cancer.